Long-term monitoring for nanomedicine implants and drugs.
about
Pioneering medical advances through nanofluidic implantable technologies.Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.Silk nanoparticles: from inert supports to bioactive natural carriers for drug delivery.Intracellular pathway and subsequent transformation of hydroxyapatite nanoparticles in the SAOS-2 osteoblast cell line.
P2860
Long-term monitoring for nanomedicine implants and drugs.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Long-term monitoring for nanomedicine implants and drugs.
@en
Long-term monitoring for nanomedicine implants and drugs.
@nl
type
label
Long-term monitoring for nanomedicine implants and drugs.
@en
Long-term monitoring for nanomedicine implants and drugs.
@nl
prefLabel
Long-term monitoring for nanomedicine implants and drugs.
@en
Long-term monitoring for nanomedicine implants and drugs.
@nl
P2860
P356
P1476
Long-term monitoring for nanomedicine implants and drugs.
@en
P2093
Michaela Kendall
P2860
P2888
P304
P356
10.1038/NNANO.2015.341
P407
P50
P577
2016-03-01T00:00:00Z